Novartis, Astellas, GSK Ads Misbranded Drugs: FDA
The U.S. Food and Drug Administration said Friday that Novartis AG, Astellas Pharma Inc. and GlaxoSmithKline PLC misled consumers about the risks and effectiveness of drugs for osteoarthritis pain, overactive bladder...To view the full article, register now.
Already a subscriber? Click here to view full article